1. Home
  2. ASRT vs CATO Comparison

ASRT vs CATO Comparison

Compare ASRT & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • CATO
  • Stock Information
  • Founded
  • ASRT 1995
  • CATO 1946
  • Country
  • ASRT United States
  • CATO United States
  • Employees
  • ASRT N/A
  • CATO N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • CATO Clothing/Shoe/Accessory Stores
  • Sector
  • ASRT Health Care
  • CATO Consumer Discretionary
  • Exchange
  • ASRT Nasdaq
  • CATO Nasdaq
  • Market Cap
  • ASRT 57.9M
  • CATO 51.1M
  • IPO Year
  • ASRT 1997
  • CATO N/A
  • Fundamental
  • Price
  • ASRT $0.65
  • CATO $2.79
  • Analyst Decision
  • ASRT Strong Buy
  • CATO
  • Analyst Count
  • ASRT 2
  • CATO 0
  • Target Price
  • ASRT $3.25
  • CATO N/A
  • AVG Volume (30 Days)
  • ASRT 207.4K
  • CATO 44.9K
  • Earning Date
  • ASRT 08-06-2025
  • CATO 05-22-2025
  • Dividend Yield
  • ASRT N/A
  • CATO 6.14%
  • EPS Growth
  • ASRT N/A
  • CATO N/A
  • EPS
  • ASRT N/A
  • CATO N/A
  • Revenue
  • ASRT $119,001,000.00
  • CATO $642,949,000.00
  • Revenue This Year
  • ASRT N/A
  • CATO N/A
  • Revenue Next Year
  • ASRT $11.91
  • CATO N/A
  • P/E Ratio
  • ASRT N/A
  • CATO N/A
  • Revenue Growth
  • ASRT N/A
  • CATO N/A
  • 52 Week Low
  • ASRT $0.51
  • CATO $2.19
  • 52 Week High
  • ASRT $1.80
  • CATO $6.70
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 49.30
  • CATO 52.51
  • Support Level
  • ASRT $0.60
  • CATO $2.93
  • Resistance Level
  • ASRT $0.68
  • CATO $3.43
  • Average True Range (ATR)
  • ASRT 0.03
  • CATO 0.23
  • MACD
  • ASRT -0.00
  • CATO 0.01
  • Stochastic Oscillator
  • ASRT 67.00
  • CATO 38.46

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About CATO Cato Corporation (The)

The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.

Share on Social Networks: